Zylö Therapeutics

Zylö Therapeutics has developed a sustained-release drug delivery system. This delivery system uses patented dry gel-derived particles, known as Z-pods™, to sustainably deliver nitric oxide and other well-known difficult-to-deliver therapeutic agents through localized administration.